Federal Register #FDA2026N6739

FDA Requests Public Comment on Cosmetic Product Regulatory Information Collection

This opportunity is a public comment request from the Food and Drug Administration (FDA) regarding information collection for cosmetic product regulatory requirements. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - OEMs and Vendors: - FDA is the only entity mentioned; no commercial OEMs or vendors are referenced - Products/Services Requested: - No procurement of products or services is requested - The notice seeks public feedback on information collection related to: - Adverse event reporting for cosmetics - Facility registration and product listing - Safety substantiation and labeling requirements - Unique or Notable Requirements: - The request is for public comment on regulatory information collection, not for goods or services - Supports implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) - Details estimated burden on industry respondents and processes for submitting comments

Description

The Food and Drug Administration (FDA) is seeking public comment on the proposed collection of information related to cosmetic products. This includes requirements for cosmetic product labeling, facility registration, and the cosmetic product listing program as established under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The information collection supports statutory and regulatory requirements including adverse event reporting, safety substantiation, and labeling. Comments on the collection must be submitted by September 15, 2026.

View original listing